Chemotherapy and targeted therapy for endocrine-pretreated or hormone receptor–negative metastatic breast cancer: ASCO guideline rapid recommendation update
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation …
B Moy, RB Rumble, LA Carey - … Journal of the American Society of …, 2023 - europepmc.org
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
[PDF][PDF] Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone-Receptor Negative Metastatic Breast Cancer: ASCO Guideline Rapid …
society.asco.org
1.1. Patients with metastatic triple-negative breast cancer with expression of programmed
cell death ligand-1 (PD-L1-positive) and no existing contraindications may be offered the …
cell death ligand-1 (PD-L1-positive) and no existing contraindications may be offered the …
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation …
B Moy, RB Rumble, LA Carey - Journal of Clinical Oncology, 2023 - ingentaconnect.com
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation …
B Moy, RB Rumble, LA Carey - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
[HTML][HTML] Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid …
B Moy, RB Rumble, LA Carey - Journal of Clinical Oncology, 2023 - ascopubs.org
Abstract ASCO Rapid Recommendations Updates highlight revisions to select ASCO
guideline recommendations as a response to the emergence of new and practice-changing …
guideline recommendations as a response to the emergence of new and practice-changing …